(Wolters Kluwer Health) Medication for addiction treatment (MAT) with buprenorphine or methadone is an appropriate and accepted treatment for pregnant women with opioid use disorder (OUD), according to a research review and update in the Journal of Addiction Medicine, the official journal of the American Society of Addiction Medicine (ASAM). The journal is published by Wolters Kluwer.
from EurekAlert! - Social and Behavioral Science http://ift.tt/2pj8dBt
No comments:
Post a Comment